Animal drug experts still warn that humans should not take the veterinary anti-parasite drug Ivermectin, while the studies have shown that it has lowered the fatality of COVID-19.
British Daily Mail Online reported on the 5th that Ivermectin had a significant effect on removing the COVID-19 virus from the patient’s body and reduced the risk of COVID-19 death by 80%.
After the research results were introduced, people’s interest in Ivermectin continued online.
However, Kang Byeong-gu, Chairman of the Korean Veterinary Pharmacy Association, said, “It is difficult to trust the results of the study, and there is no information about the exact dosage for the human body,” and warned, “We need to be careful not to let the second Fenbendazole happen.”
He stated, “There have been previous cases of Ivermectin used in humans to solve the widespread parasite problem in Africa,” but added, “It was only used for a while because the situation was very serious, and since then, there has been no use of Ivermectin on the human body.”
“The study published in the media is just a case report,” and said, “Since there are not many clinical studies, and experimental conditions and all the doses are different, it is hard to find meaning.”
In particular, he pointed out that the dosage suggested in the study is the dose given to dogs, and it is not suitable for the human body, and said, “We need to be careful to take Ivermectin on humans because the research results are not trustworthy.”
Furthermore, he warned, “There may be various attempts to find solutions on COVID-19, but it can be rather dangerous to take animal medicine like Fenbendazole.”
Meanwhile, the Korean Pharmaceutical Association will send an official letter to the local pharmaceutical community and its members, as the Ministry of Food and Drug Safety recently asked them to prevent consumers from making wrong purchases on Ivermectin, Chloroquine, and Dexamethasone.